Hysteroscopic Myomectomy for Submucosal Myomas Without Energy Instruments
1 other identifier
observational
200
1 country
1
Brief Summary
Uterine fibroid are the most common benign tumor in the female reproductive system. Although many patients with uterine fibroid do not need to be treated because they are asymptomatic, some patients can experience compression, menorrhagia, pain, irregular bleeding or infertility. The symptoms caused by uterine fibroid are related to its location and size. Submucous fibroids constitute 5-10% of all uterine fibroids.The submucous hysteromyoma is the most likely to cause symptoms, often leads to menorrhagia, irregular bleeding or infertility. Hysteroscopic myomectomy is a commonly used minimally invasive procedure. The submucous myoma can be resected out by endoscopic resectoscope with electricloop (unipolar and bipolar) . It can preserve the uterus and fertility, also effectively alleviate symptoms. However, some specific complications have also followed,such as: hemorrhage,uterine perforation, pneumonedema,infections,adhesions,etc. Uterine perforation occurs when the electrode is working, there is a high risk of injury to adjacent anatomical structures. And even without perforation, sometimes thermal injury to adjacent organs may still be discovered in a few days after surgery.In addition,Many scholars have found that hysteroscopic electromyectomy has a higher risk of intrauterine adhesion than other intrauterine operations. In order to reduce the damage caused by energy source, especially the adverse effects of thermal damage on the endometrium, the new methods of hysteroscopic myomectomy currently include: the hysteroscopic tissue removal (HTR) system, the cold loop myomectomy, the Hysteroscopy Endo Operative system (HEOS),etc. Existing studies show that,These manipulation techniques did not cause the myometrium damage by radiofrequency energy source, greatly reducing the risk of postoperative intrauterine adhesions. The cold knife hysteroscopic myomectomy in this study is a series of procedures using cold instruments(mechanically, with scissor, grasping or morcellation) to remove uterine submucosal fibroids. The purpose of this surgical technique is to make the operation safe and effective, with greater emphasis on the anatomical and physiological integrity of the myometrial and endometrial layers. This study aims to evaluate the safety and efficacy of cold knife hysteroscopic myomectomy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 23, 2023
CompletedFirst Submitted
Initial submission to the registry
October 12, 2023
CompletedFirst Posted
Study publicly available on registry
November 29, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 23, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 23, 2026
February 26, 2024
February 1, 2024
3 years
October 12, 2023
February 22, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Success rate
Total removal of intrauterine pathology with cold knife hysteroscopic myomectomy was defined as a successful operation. During the operation, whether the fibroids were successfully removed by B-ultrasound examination and naked eye
On the 1 day of surgery
failure rate
Using the cold knife method failed to remove the fibroids. During operative transfer to other surgical methods to remove submucosal fibroids, such as electrical cutting
On the 1 day of surgery
Incidence of complications
hemorrhage, pneumonedema, or perforation were registered
On the 1 day of surgery and on 1 day after surgery
surgical bleeding
Through the intraoperative blood loss assessment and preoperative and postoperative hemoglobin comparison
On the 1 day of surgery and on 1 day after surgery
Checklist of symptom relief
postoperative menstrual volume, menstrual period, anemia, postoperative fertility, postoperative intrauterine adhesions.
followed-up at 3, 6,12,24 months after surgery
Study Arms (1)
The hysteroscopic myomectomy group
Patients underwent cold knife hysteroscopic myomectomy
Eligibility Criteria
Women who met the inclusion criteria and underwent cold knife hysteroscopic myomectomy in our hospital being included in the study.
You may qualify if:
- All patients who underwent cold knife hysteroscopic myomectomy and excised tissue that showed pathology confirmation of leiomyoma.
You may not qualify if:
- Patients has gynecologic malignancy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Xu Wanwan
Yiwu, Zhejiang, 322000, China
Study Officials
- STUDY CHAIR
Wanwan Xu, Doctor
The Fourth Affiliated Hospital Zhejiang University School of Medicine
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 12, 2023
First Posted
November 29, 2023
Study Start
May 23, 2023
Primary Completion (Estimated)
May 23, 2026
Study Completion (Estimated)
May 23, 2026
Last Updated
February 26, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share